Metformin (500mg) + Pioglitazone (15mg)
Pioglaz-M Tablet SR is used in the treatment of type 2 diabetes.
10 tablet sr in 1 strip
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Pioglaz-M Tablet SR is to be taken with food.
Pioglaz-M Tablet SR may cause stomach upset if taken on empty stomach.
Pioglaz-M Tablet SR is a combination of two antidiabetic medicines: Pioglitazone and metformin. Pioglitazone is a thiazolidinedione which works by increasing the body"s sensitivity to insulin. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Together, they provide better control of blood sugar.
Related Warnings
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
Pioglaz-M Tablet SR may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Pioglaz-M Tablet SR is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Pioglaz-M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Pioglaz-M Tablet SR may be needed. Please consult your doctor.
Use of Pioglaz-M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Pioglaz-M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Pioglaz-M Tablet SR may be needed. Please consult your doctor.
Pioglaz-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
